|
|
Volumn 34, Issue 6, 2008, Pages 627-630
|
|
What is known, new and controversial about GLP-1? Minutes of the 1st European GLP-1 Club Meeting, Marseille, 28-29 May 2008
a
|
|
Author keywords
Dipeptidyl peptidase IV; DPPIV; GLP 1; Glucagon like peptide 1; Physiology; Treatment; Type 2 diabetes
|
|
Indexed keywords
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLUCAGON;
GLUCAGON LIKE PEPTIDE 1;
GLUCOSE;
INCRETIN;
INSULIN;
LIRAGLUTIDE;
METFORMIN;
PROTEINASE;
VILDAGLIPTIN;
ANTIBODY PRODUCTION;
ARTICLE;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
DRUG HALF LIFE;
DRUG MECHANISM;
GLUCAGON BLOOD LEVEL;
GLUCOSE BLOOD LEVEL;
HORMONE ACTION;
HORMONE RELEASE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
INSULIN TREATMENT;
MOLECULAR DYNAMICS;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PROTEIN DEGRADATION;
PROTEINASE INHIBITION;
SIDE EFFECT;
WEIGHT REDUCTION;
ANIMALS;
CELL DIFFERENTIATION;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
FRANCE;
GLUCAGON;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
INSULIN;
INSULIN-SECRETING CELLS;
L CELLS (CELL LINE);
MICE;
|
|
EID: 57149110807
PISSN: 12623636
EISSN: None
Source Type: Journal
DOI: 10.1016/j.diabet.2008.08.002 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
